Researcher Profiles

Return to member profile

Kim M. Hirshfield, MD, PhD

Publications since 2011

Dolfi, S. C. Jager, A. V. Medina, D. J. Haffty, B. G. Yang, J. M. Hirshfield, K. M. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett, 350:52-60, . (PMID: 24747123)

Hirshfield, K. M. Ganesan, S. Triple-negative breast cancer: molecular subtypes and targeted therapy. Curr Opin Obstet Gynecol, 26:34-40, . (PMID: 24346128)

Tian, S. Hirshfield, K. M. Jabbour, S. K. Toppmeyer, D. Haffty, B. G. Khan, A. J. Goyal, S. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients. Front Oncol, 4:277, . (PMID: 25346912, PMCID: PMC4191171)

Mehta, M. S. Dolfi, S. C. Bronfenbrener, R. Bilal, E. Chen, C. Moore, D. Lin, Y. Rahim, H. Aisner, S. Kersellius, R. D. Teh, J. Chen, S. Toppmeyer, D. L. Medina, D. J. Ganesan, S. Vazquez, A. Hirshfield, K. M. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One, 8:e69851, . (PMID: 23922822, PMCID: PMC3724883)

Tedeschi, P. M. Markert, E. K. Gounder, M. Lin, H. Dvorzhinski, D. Dolfi, S. C. Chan, L. L. Qiu, J. Dipaola, R. S. Hirshfield, K. M. Boros, L. G. Bertino, J. R. Oltvai, Z. N. Vazquez, A. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis, 4:e877, . (PMID: 24157871, PMCID: PMC3920946)

Dolfi, S. C. Chan, L. L. Qiu, J. Tedeschi, P. M. Bertino, J. R. Hirshfield, K. M. Oltvai, Z. N. Vazquez, A. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab, 1:20, . (PMID: 24279929)

Chandran, U. Hirshfield, K. M. Bandera, E. V. The role of anthropometric and nutritional factors on breast cancer risk in African-American women. Public Health Nutr, 15:738-748, . (PMID: 22122844)

Haffty, B. G. Goyal, S. Kulkarni, D. Green, C. Vazquez, A. Schiff, D. Moran, M. S. Yang, Q. Ganesan, S. Hirsfield, K. M. Evaluation of Single Nucleotide Polymorphisms (SNPs) in the p53 Binding Protein 1 (TP53BP1) Gene in Breast Cancer Patients Treated With Breast-Conserving Surgery and Whole-Breast Irradiation (BCS + RT). Int J Radiat Oncol Biol Phys, 80:385-391, . (PMID: 20646866)

Vazquez, A. Kulkarni, D. Grochola, L. F. Bond, G. L. Barnard, N. Toppmeyer, D. Levine, A. J. Hirshfield, K. M. A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence. Int J Cancer, 128:2335-2343, . (PMID: 20669227)

Mehta, M. S. Vazquez, A. Kulkarni, D. A. Kerrigan, J. E. Atwal, G. Metsugi, S. Toppmeyer, D. L. Levine, A. J. Hirshfield, K. M. Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes. Breast Cancer Res Treat, 125:861-868, . (PMID: 20658316)

Rao, M. Khan, A. J. Moran, M. S. Hirshfield, K. M. Ganesan, S. Haffty, B. G. Goyal, S. Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. J Immigr Minor Health, 13:42-48, . (PMID: 20563645)

Das, K. M. Kong, Y. Bajpai, M. Kulkarni, D. Geng, X. Mishra, P. Banerjee, D. Hirshfield, K. Transformation of benign barrett's epithelium by repeated acid and bile exposure over 65 weeks: A novel in-vitro model. Int J Cancer, 128:274-282, . (PMID: 20309934)